If you havent already, we encourage you to take our free assessment quiz to see if you qualify for our personalized weight loss solutions
Szsz, et al., 'Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer's Disease', Pharmaceuticals , vol
GLP-1 powders and, in general, powder supplements allow for higher ingredient dosages that may not fit into capsules or gummies, which improves the overall effectiveness
Research goals: Metabolic & Weight Description Retatrutide (development code LY3437943) is a synthetic, once-weekly triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors that has been the subject of peer-reviewed phase 1 and phase 2 randomized controlled trials published in The New England Journal of Medicine , The Lancet , and Nature Medicine , including investigations of body weight, glycemic control, and hepatic steatosis in adult human participants
Many users find that transitioning to maintenance doses rather than complete discontinuation better preserves improvements
Storage requirements align with Canadian climate considerations
